Form 6-K AMBEV S.A. For: Jun 30
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260529/AM2KT22CZ22YM2Z222282MOCKPHKZZ22Y282
Filed on: May 29, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso’s HARMONi-2 Study
- Apeing Presale Surpasses $80,000 in Contributions as Stage 4 Launch Approaches
- Crypto Price Today Highlights Solana Momentum as Apeing’s New Crypto Presale Stage 3 Almost Sold Out
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
